Global Targeted RNA Sequencing Supply, Demand and Key Producers, 2026-2032
The global Targeted RNA Sequencing market size is expected to reach $ 9146 million by 2032, rising at a market growth of 18.2% CAGR during the forecast period (2026-2032).
Targeted RNA Sequencing is a molecular biology technique that uses high-throughput sequencing to quantitatively analyze the expression of specific genes or gene regions. Unlike whole transcriptome sequencing, targeted RNA sequencing focuses on a defined gene panel, offering advantages such as lower cost, higher sensitivity, and simplified data processing. It is widely used in cancer subtyping, immune microenvironment profiling, drug target identification, genetic disease diagnostics, and single-cell expression analysis. With the proliferation of sequencing platforms and the advancement of multiplex PCR and probe hybridization technologies, targeted RNA sequencing has become a routine and powerful tool for clinical research institutions and biotech companies in the field of precision expression analysis.
As the concept of personalized treatment deepens and precision medicine advances, demand for targeted RNA sequencing continues to grow, especially in cancer and genetic disease applications. Government initiatives and sustained investments from pharma giants in biomarker development and bioinformatics are accelerating technology adoption in research labs and commercial institutions. Companies like Illumina and Thermo Fisher have reported a consistent CAGR of over 20% in targeted sequencing panel revenues, highlighting its growing role in genomic service portfolios. National funding surges in life sciences across the U.S., China, and Europe are further energizing the market.
Despite the promising outlook, the market faces challenges such as complex data interpretation, lack of standardization in workflows, and technical sensitivity to sample preparation. High-throughput sequencing platforms remain costly, creating adoption barriers for smaller labs and institutions. Additionally, increasingly stringent regulatory frameworks (e.g., IVD certifications, CLIA compliance) have extended timelines for clinical applications. Competitive pressure is also rising, with pricing becoming a pivotal factor and bargaining power concentrated among leading players.
Downstream demand is primarily driven by cancer research institutes, biopharma companies, and third-party CRO service providers. With the rise of cancer screening, liquid biopsy, and immunotherapy target development, the reliance on RNA-based companion diagnostics is intensifying. According to investment bank reports, targeted expression profiling is expanding its share within the RNA sequencing market and is expected to penetrate high-value segments such as solid tumor diagnostics, pediatric rare disease analysis, and quality control in cell therapy manufacturing over the next five years.
This report studies the global Targeted RNA Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted RNA Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted RNA Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted RNA Sequencing total market, 2021-2032, (USD Million)
Global Targeted RNA Sequencing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Targeted RNA Sequencing total market, key domestic companies, and share, (USD Million)
Global Targeted RNA Sequencing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Targeted RNA Sequencing total market by Type, CAGR, 2021-2032, (USD Million)
Global Targeted RNA Sequencing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Targeted RNA Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ, Natera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Targeted RNA Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Targeted RNA Sequencing Market, By Region:
1. How big is the global Targeted RNA Sequencing market?
2. What is the demand of the global Targeted RNA Sequencing market?
3. What is the year over year growth of the global Targeted RNA Sequencing market?
4. What is the total value of the global Targeted RNA Sequencing market?
5. Who are the Major Players in the global Targeted RNA Sequencing market?
6. What are the growth factors driving the market demand?
Targeted RNA Sequencing is a molecular biology technique that uses high-throughput sequencing to quantitatively analyze the expression of specific genes or gene regions. Unlike whole transcriptome sequencing, targeted RNA sequencing focuses on a defined gene panel, offering advantages such as lower cost, higher sensitivity, and simplified data processing. It is widely used in cancer subtyping, immune microenvironment profiling, drug target identification, genetic disease diagnostics, and single-cell expression analysis. With the proliferation of sequencing platforms and the advancement of multiplex PCR and probe hybridization technologies, targeted RNA sequencing has become a routine and powerful tool for clinical research institutions and biotech companies in the field of precision expression analysis.
As the concept of personalized treatment deepens and precision medicine advances, demand for targeted RNA sequencing continues to grow, especially in cancer and genetic disease applications. Government initiatives and sustained investments from pharma giants in biomarker development and bioinformatics are accelerating technology adoption in research labs and commercial institutions. Companies like Illumina and Thermo Fisher have reported a consistent CAGR of over 20% in targeted sequencing panel revenues, highlighting its growing role in genomic service portfolios. National funding surges in life sciences across the U.S., China, and Europe are further energizing the market.
Despite the promising outlook, the market faces challenges such as complex data interpretation, lack of standardization in workflows, and technical sensitivity to sample preparation. High-throughput sequencing platforms remain costly, creating adoption barriers for smaller labs and institutions. Additionally, increasingly stringent regulatory frameworks (e.g., IVD certifications, CLIA compliance) have extended timelines for clinical applications. Competitive pressure is also rising, with pricing becoming a pivotal factor and bargaining power concentrated among leading players.
Downstream demand is primarily driven by cancer research institutes, biopharma companies, and third-party CRO service providers. With the rise of cancer screening, liquid biopsy, and immunotherapy target development, the reliance on RNA-based companion diagnostics is intensifying. According to investment bank reports, targeted expression profiling is expanding its share within the RNA sequencing market and is expected to penetrate high-value segments such as solid tumor diagnostics, pediatric rare disease analysis, and quality control in cell therapy manufacturing over the next five years.
This report studies the global Targeted RNA Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted RNA Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted RNA Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted RNA Sequencing total market, 2021-2032, (USD Million)
Global Targeted RNA Sequencing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Targeted RNA Sequencing total market, key domestic companies, and share, (USD Million)
Global Targeted RNA Sequencing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Targeted RNA Sequencing total market by Type, CAGR, 2021-2032, (USD Million)
Global Targeted RNA Sequencing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Targeted RNA Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ, Natera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Targeted RNA Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Targeted RNA Sequencing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Exome Sequencing
- Enrichment Sequencing
- Amplicon Sequencing
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
- Thermo Fisher
- Illumina
- Roche Holdings
- BGI
- Eurofins
- LabCorp
- Berry Genomics
- Macrogen
- GENEWIZ
- Natera
- Novogen
- Pacific Biosciences
- Oxford Nanopore
1. How big is the global Targeted RNA Sequencing market?
2. What is the demand of the global Targeted RNA Sequencing market?
3. What is the year over year growth of the global Targeted RNA Sequencing market?
4. What is the total value of the global Targeted RNA Sequencing market?
5. Who are the Major Players in the global Targeted RNA Sequencing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Targeted RNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Targeted RNA Sequencing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Targeted RNA Sequencing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Targeted RNA Sequencing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Targeted RNA Sequencing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Targeted RNA Sequencing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Targeted RNA Sequencing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Targeted RNA Sequencing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Targeted RNA Sequencing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Targeted RNA Sequencing Players in 2025
Table 12. World Targeted RNA Sequencing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Targeted RNA Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Targeted RNA Sequencing Players
Table 15. Targeted RNA Sequencing Market: Company Product Type Footprint
Table 16. Targeted RNA Sequencing Market: Company Product Application Footprint
Table 17. Targeted RNA Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Targeted RNA Sequencing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Targeted RNA Sequencing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Targeted RNA Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Targeted RNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Targeted RNA Sequencing Revenue Market Share (2021-2026)
Table 23. China Based Targeted RNA Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Targeted RNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Targeted RNA Sequencing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Targeted RNA Sequencing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Targeted RNA Sequencing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Targeted RNA Sequencing Revenue Market Share (2021-2026)
Table 29. World Targeted RNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Targeted RNA Sequencing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Targeted RNA Sequencing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Targeted RNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Targeted RNA Sequencing Market Size by Application (2021-2026) & (USD Million)
Table 34. World Targeted RNA Sequencing Market Size by Application (2027-2032) & (USD Million)
Table 35. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher Targeted RNA Sequencing Product and Services
Table 38. Thermo Fisher Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Thermo Fisher Recent Developments/Updates
Table 40. Thermo Fisher Competitive Strengths & Weaknesses
Table 41. Illumina Basic Information, Manufacturing Base and Competitors
Table 42. Illumina Major Business
Table 43. Illumina Targeted RNA Sequencing Product and Services
Table 44. Illumina Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Illumina Recent Developments/Updates
Table 46. Illumina Competitive Strengths & Weaknesses
Table 47. Roche Holdings Basic Information, Manufacturing Base and Competitors
Table 48. Roche Holdings Major Business
Table 49. Roche Holdings Targeted RNA Sequencing Product and Services
Table 50. Roche Holdings Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Roche Holdings Recent Developments/Updates
Table 52. Roche Holdings Competitive Strengths & Weaknesses
Table 53. BGI Basic Information, Manufacturing Base and Competitors
Table 54. BGI Major Business
Table 55. BGI Targeted RNA Sequencing Product and Services
Table 56. BGI Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BGI Recent Developments/Updates
Table 58. BGI Competitive Strengths & Weaknesses
Table 59. Eurofins Basic Information, Manufacturing Base and Competitors
Table 60. Eurofins Major Business
Table 61. Eurofins Targeted RNA Sequencing Product and Services
Table 62. Eurofins Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Eurofins Recent Developments/Updates
Table 64. Eurofins Competitive Strengths & Weaknesses
Table 65. LabCorp Basic Information, Manufacturing Base and Competitors
Table 66. LabCorp Major Business
Table 67. LabCorp Targeted RNA Sequencing Product and Services
Table 68. LabCorp Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. LabCorp Recent Developments/Updates
Table 70. LabCorp Competitive Strengths & Weaknesses
Table 71. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Berry Genomics Major Business
Table 73. Berry Genomics Targeted RNA Sequencing Product and Services
Table 74. Berry Genomics Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Berry Genomics Recent Developments/Updates
Table 76. Berry Genomics Competitive Strengths & Weaknesses
Table 77. Macrogen Basic Information, Manufacturing Base and Competitors
Table 78. Macrogen Major Business
Table 79. Macrogen Targeted RNA Sequencing Product and Services
Table 80. Macrogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Macrogen Recent Developments/Updates
Table 82. Macrogen Competitive Strengths & Weaknesses
Table 83. GENEWIZ Basic Information, Manufacturing Base and Competitors
Table 84. GENEWIZ Major Business
Table 85. GENEWIZ Targeted RNA Sequencing Product and Services
Table 86. GENEWIZ Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GENEWIZ Recent Developments/Updates
Table 88. GENEWIZ Competitive Strengths & Weaknesses
Table 89. Natera Basic Information, Manufacturing Base and Competitors
Table 90. Natera Major Business
Table 91. Natera Targeted RNA Sequencing Product and Services
Table 92. Natera Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Natera Recent Developments/Updates
Table 94. Natera Competitive Strengths & Weaknesses
Table 95. Novogen Basic Information, Manufacturing Base and Competitors
Table 96. Novogen Major Business
Table 97. Novogen Targeted RNA Sequencing Product and Services
Table 98. Novogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Novogen Recent Developments/Updates
Table 100. Novogen Competitive Strengths & Weaknesses
Table 101. Pacific Biosciences Basic Information, Manufacturing Base and Competitors
Table 102. Pacific Biosciences Major Business
Table 103. Pacific Biosciences Targeted RNA Sequencing Product and Services
Table 104. Pacific Biosciences Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pacific Biosciences Recent Developments/Updates
Table 106. Pacific Biosciences Competitive Strengths & Weaknesses
Table 107. Oxford Nanopore Basic Information, Manufacturing Base and Competitors
Table 108. Oxford Nanopore Major Business
Table 109. Oxford Nanopore Targeted RNA Sequencing Product and Services
Table 110. Oxford Nanopore Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Oxford Nanopore Recent Developments/Updates
Table 112. Oxford Nanopore Competitive Strengths & Weaknesses
Table 113. Global Key Players of Targeted RNA Sequencing Upstream (Raw Materials)
Table 114. Global Targeted RNA Sequencing Typical Customers
Table 1. World Targeted RNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Targeted RNA Sequencing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Targeted RNA Sequencing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Targeted RNA Sequencing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Targeted RNA Sequencing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Targeted RNA Sequencing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Targeted RNA Sequencing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Targeted RNA Sequencing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Targeted RNA Sequencing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Targeted RNA Sequencing Players in 2025
Table 12. World Targeted RNA Sequencing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Targeted RNA Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Targeted RNA Sequencing Players
Table 15. Targeted RNA Sequencing Market: Company Product Type Footprint
Table 16. Targeted RNA Sequencing Market: Company Product Application Footprint
Table 17. Targeted RNA Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Targeted RNA Sequencing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Targeted RNA Sequencing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Targeted RNA Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Targeted RNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Targeted RNA Sequencing Revenue Market Share (2021-2026)
Table 23. China Based Targeted RNA Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Targeted RNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Targeted RNA Sequencing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Targeted RNA Sequencing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Targeted RNA Sequencing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Targeted RNA Sequencing Revenue Market Share (2021-2026)
Table 29. World Targeted RNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Targeted RNA Sequencing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Targeted RNA Sequencing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Targeted RNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Targeted RNA Sequencing Market Size by Application (2021-2026) & (USD Million)
Table 34. World Targeted RNA Sequencing Market Size by Application (2027-2032) & (USD Million)
Table 35. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher Targeted RNA Sequencing Product and Services
Table 38. Thermo Fisher Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Thermo Fisher Recent Developments/Updates
Table 40. Thermo Fisher Competitive Strengths & Weaknesses
Table 41. Illumina Basic Information, Manufacturing Base and Competitors
Table 42. Illumina Major Business
Table 43. Illumina Targeted RNA Sequencing Product and Services
Table 44. Illumina Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Illumina Recent Developments/Updates
Table 46. Illumina Competitive Strengths & Weaknesses
Table 47. Roche Holdings Basic Information, Manufacturing Base and Competitors
Table 48. Roche Holdings Major Business
Table 49. Roche Holdings Targeted RNA Sequencing Product and Services
Table 50. Roche Holdings Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Roche Holdings Recent Developments/Updates
Table 52. Roche Holdings Competitive Strengths & Weaknesses
Table 53. BGI Basic Information, Manufacturing Base and Competitors
Table 54. BGI Major Business
Table 55. BGI Targeted RNA Sequencing Product and Services
Table 56. BGI Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BGI Recent Developments/Updates
Table 58. BGI Competitive Strengths & Weaknesses
Table 59. Eurofins Basic Information, Manufacturing Base and Competitors
Table 60. Eurofins Major Business
Table 61. Eurofins Targeted RNA Sequencing Product and Services
Table 62. Eurofins Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Eurofins Recent Developments/Updates
Table 64. Eurofins Competitive Strengths & Weaknesses
Table 65. LabCorp Basic Information, Manufacturing Base and Competitors
Table 66. LabCorp Major Business
Table 67. LabCorp Targeted RNA Sequencing Product and Services
Table 68. LabCorp Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. LabCorp Recent Developments/Updates
Table 70. LabCorp Competitive Strengths & Weaknesses
Table 71. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 72. Berry Genomics Major Business
Table 73. Berry Genomics Targeted RNA Sequencing Product and Services
Table 74. Berry Genomics Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Berry Genomics Recent Developments/Updates
Table 76. Berry Genomics Competitive Strengths & Weaknesses
Table 77. Macrogen Basic Information, Manufacturing Base and Competitors
Table 78. Macrogen Major Business
Table 79. Macrogen Targeted RNA Sequencing Product and Services
Table 80. Macrogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Macrogen Recent Developments/Updates
Table 82. Macrogen Competitive Strengths & Weaknesses
Table 83. GENEWIZ Basic Information, Manufacturing Base and Competitors
Table 84. GENEWIZ Major Business
Table 85. GENEWIZ Targeted RNA Sequencing Product and Services
Table 86. GENEWIZ Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GENEWIZ Recent Developments/Updates
Table 88. GENEWIZ Competitive Strengths & Weaknesses
Table 89. Natera Basic Information, Manufacturing Base and Competitors
Table 90. Natera Major Business
Table 91. Natera Targeted RNA Sequencing Product and Services
Table 92. Natera Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Natera Recent Developments/Updates
Table 94. Natera Competitive Strengths & Weaknesses
Table 95. Novogen Basic Information, Manufacturing Base and Competitors
Table 96. Novogen Major Business
Table 97. Novogen Targeted RNA Sequencing Product and Services
Table 98. Novogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Novogen Recent Developments/Updates
Table 100. Novogen Competitive Strengths & Weaknesses
Table 101. Pacific Biosciences Basic Information, Manufacturing Base and Competitors
Table 102. Pacific Biosciences Major Business
Table 103. Pacific Biosciences Targeted RNA Sequencing Product and Services
Table 104. Pacific Biosciences Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pacific Biosciences Recent Developments/Updates
Table 106. Pacific Biosciences Competitive Strengths & Weaknesses
Table 107. Oxford Nanopore Basic Information, Manufacturing Base and Competitors
Table 108. Oxford Nanopore Major Business
Table 109. Oxford Nanopore Targeted RNA Sequencing Product and Services
Table 110. Oxford Nanopore Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Oxford Nanopore Recent Developments/Updates
Table 112. Oxford Nanopore Competitive Strengths & Weaknesses
Table 113. Global Key Players of Targeted RNA Sequencing Upstream (Raw Materials)
Table 114. Global Targeted RNA Sequencing Typical Customers
LIST OF FIGURES
Figure 1. Targeted RNA Sequencing Picture
Figure 2. World Targeted RNA Sequencing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Targeted RNA Sequencing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Targeted RNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Targeted RNA Sequencing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 13. Targeted RNA Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Targeted RNA Sequencing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Targeted RNA Sequencing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Targeted RNA Sequencing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Targeted RNA Sequencing Markets in 2025
Figure 27. United States VS China: Targeted RNA Sequencing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Targeted RNA Sequencing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Targeted RNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Targeted RNA Sequencing Market Size Market Share by Type in 2025
Figure 31. Exome Sequencing
Figure 32. Enrichment Sequencing
Figure 33. Amplicon Sequencing
Figure 34. World Targeted RNA Sequencing Market Size Market Share by Type (2021-2032)
Figure 35. World Targeted RNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Targeted RNA Sequencing Market Size Market Share by Application in 2025
Figure 37. Research Institutes
Figure 38. Hospitals & Clinics
Figure 39. Biotechnology Company
Figure 40. Diagnostic Lab
Figure 41. World Targeted RNA Sequencing Market Size Market Share by Application (2021-2032)
Figure 42. Targeted RNA Sequencing Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Targeted RNA Sequencing Picture
Figure 2. World Targeted RNA Sequencing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Targeted RNA Sequencing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Targeted RNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Targeted RNA Sequencing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Targeted RNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 13. Targeted RNA Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Targeted RNA Sequencing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Targeted RNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Targeted RNA Sequencing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Targeted RNA Sequencing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Targeted RNA Sequencing Markets in 2025
Figure 27. United States VS China: Targeted RNA Sequencing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Targeted RNA Sequencing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Targeted RNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Targeted RNA Sequencing Market Size Market Share by Type in 2025
Figure 31. Exome Sequencing
Figure 32. Enrichment Sequencing
Figure 33. Amplicon Sequencing
Figure 34. World Targeted RNA Sequencing Market Size Market Share by Type (2021-2032)
Figure 35. World Targeted RNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Targeted RNA Sequencing Market Size Market Share by Application in 2025
Figure 37. Research Institutes
Figure 38. Hospitals & Clinics
Figure 39. Biotechnology Company
Figure 40. Diagnostic Lab
Figure 41. World Targeted RNA Sequencing Market Size Market Share by Application (2021-2032)
Figure 42. Targeted RNA Sequencing Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
